CIK: 1691428 - Address: C/O Mpm Capital, 399 Boylston Street, Suite 1100, Boston, MA 02116
13 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y
9/20/21 17:31
9/16/21
CGEMCullinan Oncology, Inc.HealthBioPrdBiological Products, (No DiagUbs Oncology Impact Fund L.P.MATS-9129.060-307,648D
9/16/21 16:45
9/14/21
CGEMCullinan Oncology, Inc.HealthBioPrdBiological Products, (No DiagUbs Oncology Impact Fund L.P.MATS.m-39529.170-1407,651D
9/13/21 18:24
9/9/21
CGEMCullinan Oncology, Inc.HealthBioPrdBiological Products, (No DiagUbs Oncology Impact Fund L.P.MATS.m-68029.230-2307,665D
9/8/21 18:20
9/3/21
CGEMCullinan Oncology, Inc.HealthBioPrdBiological Products, (No DiagUbs Oncology Impact Fund L.P.MATS.m-1,42029.200-49-17,688D
9/2/21 17:26
8/31/21
CGEMCullinan Oncology, Inc.HealthBioPrdBiological Products, (No DiagUbs Oncology Impact Fund L.P.MATS.m-71729.500-2407,737D
8/31/21 16:47
8/27/21
CGEMCullinan Oncology, Inc.HealthBioPrdBiological Products, (No DiagUbs Oncology Impact Fund L.P.MATS.m-1,29729.240-44-17,761D
8/25/21 19:42
8/23/21
CGEMCullinan Oncology, Inc.HealthBioPrdBiological Products, (No DiagUbs Oncology Impact Fund L.P.MATS.m-3,10129.290-106-17,805D
8/12/21 16:55
8/11/21
CGEMCullinan Oncology, Inc.HealthBioPrdBiological Products, (No DiagUbs Oncology Impact Fund L.P.MATS-7329.050-307,911D
1/14/21 17:54
1/12/21
CGEMCullinan Management, Inc.HealthBioPrdBiological Products, (No DiagUbs Oncology Impact Fund L.P.E9TP.d6,30021.00030047,914D
10/8/20 18:26
10/6/20
ONCROncorus, Inc.DEHealthDrugPharmaceutical PreparationsUbs Oncology Impact Fund L.P.E9TP.d2,26815.00015172,377D
2/21/19 18:06
2/19/19
TCRRTcr2 Therapeutics Inc.DEHealthBioPrdBiological Products, (No DiagUbs Oncology Impact Fund L.P.MATP.d10,00015.000667253,371D
2/14/19 17:34
2/12/19
HARPHarpoon Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagUbs Oncology Impact Fund L.P.MATS.d-614.000003,898D
2/14/19 17:34
2/12/19
HARPHarpoon Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagUbs Oncology Impact Fund L.P.MATP.d3,50014.00025073,898D

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact